Cambridge Associates LLC Collegium Pharmaceutical, Inc Transaction History

Cambridge Associates LLC

  • $2.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$17.5 - $21.35 $446,670 - $544,937
-25,524 Closed
0 $0
Q3 2021

Dec 20, 2022
BUY
$17.75 - $25.39 $453,051 - $648,054
25,524 New
25,524 $504,000
Q3 2021

May 10, 2022
BUY
$17.75 - $25.39 $453,051 - $648,054
25,524 New
25,524 $504,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Cambridge Associates LLC Portfolio

Follow Cambridge Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Associates LLC , based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email